4//SEC Filing
HEALTHEQUITY INC 4
Accession 0001140361-16-090424
$HQYCIK 0001428336operating
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 8:44 PM ET
Size
22.1 KB
Accession
0001140361-16-090424
Insider Transaction Report
Form 4
Rana Manu S
Director
Transactions
- Sale
Common Stock
2016-12-19$40.13/sh−124,752$5,006,597→ 97,600 total(indirect: See footnote) - Sale
Common Stock
2016-12-19$41.01/sh−1,600$65,616→ 96,000 total(indirect: See footnote) - Sale
Common Stock
2016-12-20$40.11/sh−96,000$3,850,762→ 0 total(indirect: See footnote) - Sale
Common Stock
2016-12-16$41.26/sh−111,975$4,620,189→ 270,377 total(indirect: See footnote) - Sale
Common Stock
2016-12-16$42.22/sh−48,025$2,027,836→ 222,352 total(indirect: See footnote)
Holdings
- 15,000
Stock Option (right to buy)
Exercise: $21.27Exp: 2026-02-01→ Common Stock (15,000 underlying) - 795
Restricted Stock Unit
→ Common Stock (795 underlying) - 7,500
Stock Option (right to buy)
Exercise: $1.25Exp: 2021-10-25→ Common Stock (7,500 underlying) - 15,000
Stock Option (right to buy)
Exercise: $1.25Exp: 2022-04-26→ Common Stock (15,000 underlying) - 15,000
Stock Option (right to buy)
Exercise: $1.50Exp: 2023-05-09→ Common Stock (15,000 underlying) - 15,000
Stock Option (right to buy)
Exercise: $14.00Exp: 2024-07-30→ Common Stock (15,000 underlying) - 15,000
Stock Option (right to buy)
Exercise: $25.39Exp: 2025-03-26→ Common Stock (15,000 underlying)
Footnotes (9)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.97 to $41.96, inclusive. The reporting person undertakes to provide to the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), (4) and (5) to this Form 4.
- [F2]All securities are held of record by Financial Partners Fund I, L.P. ("FPF I"), a Delaware limited partnership. The reporting person is a managing principal of FPF I. The reporting person disclaims beneficial ownership of the securities held by FPF I except to the extent of his pecuniary interest therein.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.97 to $42.65, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.99 to $40.75, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.07 to $40.325, inclusive.
- [F6]The option became exercisable as to 7,500 shares upon the reporting person's reelection to the issuer's board of directors at the issuer's 2016 Annual Meeting of Stockholders held on June 23, 2016. The remaining 7,500 shares will become exercisable on January 31, 2017; provided, that the reporting person continues to serve as a director of the issuer through such date.
- [F7]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F8]The restricted stock units vested as to 397 shares on August 1, 2016 and will vest as to the remaining 398 shares on November 1, 2016. Vested shares will be delivered to the reporting person upon the earlier of a change of control of the issuer (as defined in the issuer's 2014 equity incentive plan), or the reporting person's termination of service (as defined in the issuer's 2014 equity incentive plan), or the reporting person's death.
- [F9]The option is immediately exercisable.
Documents
Issuer
HEALTHEQUITY INC
CIK 0001428336
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001428336
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 8:44 PM ET
- Size
- 22.1 KB